Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Novel Microscope Enables Direct Mass Spectrometry Analysis

By BiotechDaily International staff writers
Posted on 07 May 2013
Image: The iMScope –  Shimadzu’s novel imaging mass microscope (Photo courtesy of Shimadzu).
Image: The iMScope – Shimadzu’s novel imaging mass microscope (Photo courtesy of Shimadzu).
A unique imaging mass microscope has been developed as a new research tool that offers mass spectrometric analysis capability in a single instrument and resolution enabling the visualization of the sub-cellular distribution of molecules.

The positional information of molecules is lost in traditional mass spectrometric analysis. Shimadzu Corporation (Kyoto, Japan) introduces the “iMScope” imaging mass microscope, a new hybrid type of microscope that combines both an optical microscope and an atmospheric pressure ionization mass spectrometer. The optical microscope allows the observation of high-resolution morphological images, and the hybrid ion trap time of flight mass spectrometer allows both identification and visualization of the distribution of specific molecules in the sectioned sample of interest. In addition, the relative abundance of specific molecules (such as drugs and their metabolites) localized in different tissues can be resolved and compared. The dedicated software for the iMScope, “Imaging MS Solution,” can set all operational parameters for viewing optical microscope images, and many sets of operation parameters are available as default method files; hence, users can perform the imaging mass spectrometry without troublesome additional settings.

Proprietary ultrafocusing laser optics and the highly reproducible, high precision 3D automated sample transfer stage result in a superior spatial mass spectrometry resolution of 5 µm—finest spatial resolution in imaging mass spectrometry, using matrix assisted laser desorption ionization (MALDI-TOF) mass spectrometer, commercially available. The iMScope is capable of analyzing living cells or tissue samples by atmosphere MALDI. By superimposing the two images obtained based on these different principles, the team of scientists from Shimadzu, Hamamatsu University of Medicine, and Keio University have created this powerful new research tool.

The iMScope expands potential research opportunities to a diversity of fields, including direct analyses of biological samples as well as of manufactured devices. Potential biological applications include disease biomarker research and functional biology research, such as for development of early stage cancer indicators with biomarkers in cancer tissue; for analysis of micro tissue (smaller than 10 µm; e.g., pigment layer of the retina); as a new pharmacokinetics tool monitoring drug metabolism; and for advancing agricultural and horticultural products via locating the distribution of key compounds. The iMScope is also well suited for various industrial applications, particularly for defect analysis of electronic components and synthetic polymer materials.

In addition to enabling direct analysis of optical microscope samples, the use of atmosphere MALDI, compared to vacuum MALDI, enables analysis of volatile molecules and biological tissues closer living conditions, as well as shorter instrument start-up time. Additionally, the high speed Nd:YAG laser can ionize molecules at 1 kHz, and original ion optics can acquire the ions (which are ionized by several laser shots) and analyze those at once, as this novel technology provides about 100 times faster high-speed imaging mass spectrometry than conventional mass spectrometers. Hence, the ultra-fast performance of the iMScope also accelerates research progress.

The iMScope will be presented at both KSBMB 2013, Korean Society of Biochemistry and Molecular Biology (May 14-16, 2013) and ASMS 2013, American Society of Mass Spectrometry (June 9-13, 2013, in Minneapolis, MN, USA), in conjunction with the new iMLayer, matrix sample preparation device for tissue imaging.

Related Links:
Shimadzu
iMScope


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Differences in the structure of a small lung artery (top row) and heart cross section (lower row) of rodents without disease (far left column); with pulmonary hypertension (middle) and a diseased rodent treated with the HDL peptide (right). Note the much narrowed lung artery, and thick walls and larger chamber of the heart in the diseased animal and improvements with 4F peptide treatment (Photo courtesy of UCLA - University of California, Los Angeles).

Apolipoprotein A-1 Mimetic Peptide Reverses Pulmonary Hypertension in Rodent Models

A small peptide that mimics the activity of apolipoprotein A-1 (apo A-1), the main protein component of the high density lipoproteins (HDL), counteracted the effects of oxidized lipids and alleviated symptoms... Read more

Drug Discovery

view channel
Image: The five stages of biofilm development: (1) Initial attachment, (2) Irreversible attachment, (3) Maturation I, (4) Maturation II, and (5) Dispersion. Each stage of development in the diagram is paired with a photomicrograph of a developing P. aeruginosa biofilm. All photomicrographs are shown to same scale (Photo courtesy of Wikimedia Commons).

Ionic Liquids Disperse Bacterial Biofilms and Increase Antibiotic Susceptibility

The ionic liquid choline-geranate was shown to effectively eliminate the protective biofilm generated by bacteria such as Salmonella enterica and Pseudomonas aeruginosa and to significantly increase the... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.